These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1675711)

  • 21. The European role on traditional herbal medicinal products and traditional plant food supplements.
    Serafini M; Stanzione A; Foddai S; Anton R; Delmulle L
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S93-4. PubMed ID: 22955367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Counterfeiting and piracy of pharmaceuticals.
    Grackin A
    IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
    [No Abstract]   [Full Text] [Related]  

  • 23. EU approval system leaves door open for dangerous devices.
    Cohen D
    BMJ; 2012 Oct; 345():e7173. PubMed ID: 23097554
    [No Abstract]   [Full Text] [Related]  

  • 24. [Guarantee of drug quality for animal health and consumer protection].
    Kroker R
    Dtsch Tierarztl Wochenschr; 1994 Jul; 101(7):278-80. PubMed ID: 7924965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encoding technical information in GM organisms.
    Marillonnet S; Klimyuk V; Gleba Y
    Nat Biotechnol; 2003 Mar; 21(3):224-6. PubMed ID: 12610560
    [No Abstract]   [Full Text] [Related]  

  • 26. Informed by the European Union experience: what the United States can anticipate and learn from the European Union's regulatory approach to biosimilars.
    Gitter DM
    Seton Hall Law Rev; 2011; 41(2):559-92. PubMed ID: 21739759
    [No Abstract]   [Full Text] [Related]  

  • 27. The drug safety system conundrum.
    Tiedt TN
    Food Drug Law J; 2007; 62(3):547-558. PubMed ID: 17915396
    [No Abstract]   [Full Text] [Related]  

  • 28. Shiley saga leads to improved communication.
    Farley D
    FDA Consum; 1994; 28(1):12-7. PubMed ID: 10131486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neither protective nor harmonized: the crossborder regulation of medical devices in the EU.
    Jarman H; Rozenblum S; Huang TJ
    Health Econ Policy Law; 2021 Jan; 16(1):51-63. PubMed ID: 32631465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Review 2001: The veterinary drug legislation is being revised. A brief insight into the European Union legislation process concerning drugs].
    Hulsen J; de Groot H
    Tijdschr Diergeneeskd; 2003 Sep; 128(17):521-3. PubMed ID: 14582150
    [No Abstract]   [Full Text] [Related]  

  • 32. [The European regulation for cosmetics : Legislative aspect from the German point of view].
    Butschke A; Dross A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):606-9. PubMed ID: 20458455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond the US submisson process.
    Donawa M
    Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Commission--Directorate General DG XXIV Consumer Policy and Consumer Health Protection. Notes of Guidance for testing of cosmetic ingredients for their safety evaluation (Second Revision). Adopted: 20 December 1996. Revised: 16 January 1997. The Scientific Committee on Cosmetology of the European Commission.
    Food Chem Toxicol; 1999 Apr; 37(4):357-85. PubMed ID: 10418954
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug safety: a contrarian's point of view.
    Cobert B
    Food Drug Law J; 2007; 62(3):501-12. PubMed ID: 17915392
    [No Abstract]   [Full Text] [Related]  

  • 36. Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.
    Kelly DP; Bachorik LL
    Food Drug Law J; 2005; 60(3):339-46. PubMed ID: 16304741
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulatory pathways in the European Union.
    Kohler M
    MAbs; 2011; 3(3):241-2. PubMed ID: 21487236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of medicinal plants for public health--European community monographs on herbal substances.
    Knöss W; Chinou I
    Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticipating new consumer protection challenges in the food and drug marketplace.
    Parnes LB
    Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
    [No Abstract]   [Full Text] [Related]  

  • 40. Semper fidelis--consumer protection for patients with implanted medical devices.
    Maisel WH
    N Engl J Med; 2008 Mar; 358(10):985-7. PubMed ID: 18322280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.